» Articles » PMID: 22008525

P32 Regulates Mitochondrial Morphology and Dynamics Through Parkin

Overview
Journal Neuroscience
Specialty Neurology
Date 2011 Oct 20
PMID 22008525
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in parkin were first identified in a group of Japanese patients who developed autosomal recessive juvenile Parkinsonism with clinical symptoms similar to idiopathic Parkinson's disease (PD). Parkin is an E3 ligase that targets a number of substrates for ubiquitination. Recent studies show that parkin together with PINK1, another familial-linked PD gene product, is involved in the regulation of mitochondrial dynamics in the cell. In this study, we have identified a mitochondrial protein p32 as a novel interactor of parkin in the brain. We found that p32 can regulate mitochondrial morphology and dynamics by promoting parkin degradation through autophagy. These results suggest that parkin might be an important effector in the regulation of morphology and dynamics of mitochondria.

Citing Articles

A new peptide inhibitor of C1QBP exhibits potent anti-tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair.

Li X, Wu Y, Zhang M, Wang F, Yin H, Zhang Y Clin Transl Med. 2025; 15(1):e70162.

PMID: 39748215 PMC: 11695203. DOI: 10.1002/ctm2.70162.


Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.

Egusquiza-Alvarez C, Moreno-Londono A, Alvarado-Ortiz E, Ramos-Godinez M, Sarabia-Sanchez M, Castaneda-Patlan M Int J Mol Sci. 2024; 25(5).

PMID: 38473963 PMC: 10931692. DOI: 10.3390/ijms25052712.


Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.

Ren Y, Jiang Z, Wang J, He Q, Li S, Gu X Mol Neurobiol. 2024; 61(10):7968-7988.

PMID: 38453793 DOI: 10.1007/s12035-024-04090-y.


Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.

Tio M, Wen R, Choo C, Tan J, Chua A, Xiao B J Biomed Sci. 2024; 31(1):24.

PMID: 38395904 PMC: 10893700. DOI: 10.1186/s12929-024-01010-z.


p32/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer.

Yu C, Peng Z, Wang T, Qu X, Yang P, Huang S Acta Biochim Biophys Sin (Shanghai). 2023; 56(1):34-43.

PMID: 38151998 PMC: 10875347. DOI: 10.3724/abbs.2023247.